BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2430328)

  • 1. The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.
    Mihăilescu E; Micu D; Cheţa N; Chiriloiu C; Georgescu M; Vilău C
    Med Interne; 1986; 24(3):227-33. PubMed ID: 2430328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic behaviour of the lymphocytes from serous effusions in various benign internal diseases.
    Mihăilescu E; Chiriloiu C; Cheţa N; Micu D
    Med Interne; 1985; 23(2):121-7. PubMed ID: 4023585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of c-Ha-ras oncogene expression in pleural and peritoneal smear effusions by in situ hybridization.
    Athanassiadou PP; Veneti SZ; Kyrkou KA; Athanassiades PH
    Cancer Detect Prev; 1993; 17(6):585-90. PubMed ID: 8275510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
    Pinto MM
    Acta Cytol; 1986; 30(3):240-4. PubMed ID: 3521174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and cytochemical investigation of human mesothelial cells from pleural and peritoneal effusions: a light and electron microscopy study.
    Efrati P; Nir E
    Isr J Med Sci; 1976 Jul; 12(7):662-73. PubMed ID: 972021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme cytochemistry of benign and malignant cells in pleural and peritoneal fluid.
    Blonk DI; Schaberg A; Willighagen RG
    Acta Cytol; 1967; 11(6):460-5. PubMed ID: 4169938
    [No Abstract]   [Full Text] [Related]  

  • 11. The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions.
    Bauer Z; Milíc N; Handl S; Koprcina M
    Acta Cytol; 1977; 21(1):141-6. PubMed ID: 264748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
    van Hensbergen Y; Broxterman HJ; Hanemaaijer R; Jorna AS; van Lent NA; Verheul HM; Pinedo HM; Hoekman K
    Clin Cancer Res; 2002 Dec; 8(12):3747-54. PubMed ID: 12473585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
    Granados R; Cibas ES; Fletcher JA
    Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lactate dehydrogenases in malignant and non-malignant diseases.
    Oladipo OO; Ajala MO; Afonja OA
    Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].
    Zhang X; Cao J; Zheng S; Li XF
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):411-3. PubMed ID: 12895345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with an enzyme cytochemical test for tumor cells in pleural fluid and ascites (author's transl)].
    Eckert H; Wildner GP
    Arch Geschwulstforsch; 1979; 49(4):305-10. PubMed ID: 496568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions of patients with cancer.
    Domagala W; Emeson EE; Koss LG
    J Natl Cancer Inst; 1978 Aug; 61(2):295-300. PubMed ID: 308101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM; Vives M
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.